Adolescent exposure to cannabis as a risk factor for psychiatric disorders
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Adolescence represents a critical period for brain development and the endocannabinoid system plays a crucial role in the regulation of neuronal refinement during this period. Cannabis is the most consumed drug among adolescent people and its heavy use may affect maturational refinement by disrupting the regulatory role of the endocannabinoid system. In animals, adolescent cannabinoid exposure has been reported to cause long-term impairment in specific components of learning and memory and to differentially affect emotional reactivity with milder effects on anxiety behaviour and more pronounced effects on depression-like behaviour. Moreover, adolescent exposure to cannabinoids might represent a risk factor for developing psychotic-like symptoms at adulthood. Also epidemiological studies suggest that heavy adolescent cannabis use may increase the risk of cognitive abnormalities, psychotic illness, mood disorders and other illicit substance use later in life. In conclusion, the available data point to the hypothesis that heavy cannabis use in adolescence could increase the risk of developing psychiatric disorders, especially in people who already have a vulnerability to develop a psychiatric syndrome. Only few papers have investigated the neurobiological substrates of this vulnerability, thus further studies are needed to clarify the molecular mechanisms underlying the effect of cannabis on the adolescent brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brain development during childhood and adolescence: a longitudinal MRI study
Giedd, J. N., Blumenthal, J., Jeffries, N. O., Castellanos, F. X., Liu, H., Zijdenbos, A., Paus, T., Evans, A. C., & Rapoport, J. L. (1999) · Nature Neuroscience · doi:10.1038/13158 · Cited by 5,552
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092 · cited 3×
“CB2 receptors were cloned a few years later (Munro et al., 1993) and whilst they were thought to be predominately located in immune cells in tissues such as the spleen and liver, there are recent papers showing that cannabinoid CB2 receptors may also be expressed in neurons (Brusco et al., 2008;…”
BackgroundStructure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Synaptic Activity and the Construction of Cortical Circuits
Katz, L. C., & Shatz, C. J. (1996) · Science · doi:10.1126/science.274.5290.1133 · Cited by 3,048 · cited 1×
“This aim is reached through a process of synaptic refinement, by which some connections between brain cells are pruned and eliminated, whereas ‘useful’ neurons, synapses and dendrites are preserved for the adult brain (Cohen-Cory, 2002; Katz and Shatz, 1996; Luna, 2009; Whitford et al., 2007).”
BackgroundSteinberg, L., & Morris, A. S. (2001) · Annual Review of Psychology · doi:10.1146/annurev.psych.52.1.83 · Cited by 2,517
2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain
Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196
Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159 · cited 1×
“The cannabinoid CB1 receptor is a presynaptic receptor widely expressed throughout the brain with high density in the striatum, hippocampus, and cerebellum, and moderate to low densities in the amygdala, midbrain and cerebral cortex (Glass and Felder, 1997; Herkenham et al., 1991).”
BackgroundAnimal models of neuropsychiatric disorders
Nestler, E. J., & Hyman, S. E. (2010) · Nature Neuroscience · doi:10.1038/nn.2647 · Cited by 2,023 · cited 2×
“However, numerous linkage and association studies with candidate genes for schizophrenia have excluded the possibility that schizophrenia is related to a single gene mutation: transmission is now thought more likely to involve multiple susceptible loci (for reviews see Marcotte et al., 2001; Nestler and Hyman, 2010; R…”
BackgroundThe molecular logic of endocannabinoid signalling
Piomelli, D. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1247 · Cited by 1,957 · cited 1×
“Both are arachidonic acid derivatives produced from phospholipid precursors postsynaptically through activity-dependent activation of specific phospholipase enzymes (Piomelli, 2003).”
BackgroundThe orphan receptor GPR55 is a novel cannabinoid receptor
Ryberg, E., Larsson, N., Sjögren, S., Hjorth, S., Hermansson, N., Leonova, J., Elebring, T., Nilsson, K., Drmota, T., & Greasley, P. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707460 · Cited by 1,568 · cited 1×
“Moreover, other putative endocannabinoid receptors are the ‘orphan’ G protein coupled receptor GPR55 (Ryberg et al., 2007) and the peroxisome proliferator activated receptor (PPAR) (O’Sullivan, 2007).”
Background
Cited by
Maturation of the adolescent brain
Sharma, S., Arain, Mathur, Rais, Nel, Sandhu, Haque, & Johal (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s39776 · Cited by 1,249
Ligresti, A., De Petrocellis, L., & Di Marzo, V. (2016) · Physiological Reviews · doi:10.1152/physrev.00002.2016 · Cited by 469
Cannabis and adolescent brain development.
Lubman, D. I., Cheetham, A., & Yücel, M. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.009 · Cited by 360
Lisdahl, K. M., Wright, N. E., Medina-Kirchner, C., Maple, K. E., & Shollenbarger, S. (2014) · Current Addiction Reports · doi:10.1007/s40429-014-0019-6 · Cited by 160
Zamberletti, E., Beggiato, S., Steardo, L., Prini, P., Antonelli, T., Ferraro, L., Rubino, T., & Parolaro, D. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.10.028 · Cited by 147
“This risk appears to be highly dependent upon the frequency of cannabis use (Di Forti et al., 2009) as well as the age when drug use begins, adolescence representing a more vulnerable timewindow for the longterm adverse effect of cannabis consumption (Malone et al., 2010; Rubino et al., 2012).”
BackgroundSelf-citation
Metadata
- Authors
- Rubino, T., Zamberletti, E., & Parolaro, D.
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2011-07-18
- Volume
- 26
- Issue
- 1
- Pages
- 177-188
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2102040370
- Cited by
- 153
- References
- 28
- FWCI
- 8.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Adolescent exposure to cannabis as a risk factor for psychiatric disorders. https://app.cochat.ai/papers/10.1177/0269881111405362
- The paper
- Rubino, T., Zamberletti, E., & Parolaro, D. (2012). Adolescent exposure to cannabis as a risk factor for psychiatric disorders. Journal of Psychopharmacology. https://doi.org/10.1177/0269881111405362
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.